← Back to the boardHill
FDA has opened a docket soliciting comments on a public workshop covering next-generation sequencing for adventitious agent detection in biologics, with comments due November 23, 2026.
Why it’s here: FDA public workshop on next-generation sequencing for adventitious agent detection in biologics falls under biotechnology regulation and biosecurity policy, with a federal regulatory docket and comment period.
Item
11:59 PMAgencyFDAFDA has opened a docket soliciting comments on a public workshop covering next-generation sequencing for adventitious agent detection in biologics, with comments due November 23, 2026.Comment deadlineBiotechDetails
About
- Food and Drug Administration